Novo Nordisk A/S
About Novo Nordisk
Novo Nordisk A/S is a healthcare company engaged in the development, manufacture, and marketing of pharmaceutical products globally.
It operates through two segments:
-
Diabetes and Obesity Care: This segment delivers a comprehensive range of products, including insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity treatments, and therapies for other chronic diseases.
-
Biopharmaceuticals: Focuses on products for haemophilia, growth disorders, and hormone replacement therapy.
Novo Nordisk maintains collaborative agreements to enhance research and product development. Notably, it has partnerships with Gilead Sciences, Inc., and Lumen Bioscience, Inc., the latter focusing on strategies for delivering oral biologics to treat cardiometabolic diseases.
Founded in 1923, the company is headquartered in Bagsvaerd, Denmark.
Novo Nordisk's Business Strategy
Novo Nordisk focuses on developing and commercializing innovative therapies for chronic diseases, with a particular emphasis on diabetes, obesity and metabolic disorders. The company has built a global leadership position in glucagon-like peptide-1 (GLP-1) based medicines, which regulate blood sugar and appetite. Flagship products include…
Available on Finplify
Free account required
Our Take on Novo Nordisk
Pros:
✅ Diabetes & Obesity Care Leader: Novo Nordisk is the world’s largest insulin manufacturer and a dominant player in the fast-growing GLP-1 drug class, which treats both diabetes and obesity. Its therapies have shown strong clinical results and high patient demand globally.
✅ **Obesity Treatments…
Available on Finplify
Free account required
Company Details
Key Metrics
Fundamental Analysis
Proprietary 5-category scoring system
Score Fingerprint
Section Scores
Full Breakdown & Peer Ranking
See the detailed score for every metric and how this stock ranks against its sector peers
Unlock the full research on Novo Nordisk
Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.
300+ Curated Stocks
A hand-picked universe of world-class businesses across every major market and sector.
AI Analyst Briefings
Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.
Proprietary Fundamentals
Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.